1. Aurora Cannabis expands medical pricing eligibility to CAD 60,000. 2. Over half of Canadian adults qualify for the new pricing program. 3. New products launched alongside the pricing program. 4. Aurora aims to improve medical cannabis accessibility for diverse groups. 5. Company promotes commitment to quality cannabis in healthcare.
The expansion of eligibility increases customer base. Historical data shows increased revenue during similar pricing strategies.
Expanded eligibility can significantly enhance revenue, attracting more patients.
Immediate customer engagement expected; patient enrollment likely to rise quickly.
NASDAQ | TSX: ACB
EDMONTON, AB, June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from $40,000 to $60,000 CAD for Aurora patients through AuroraMedical.com.